Premedix Academy
6
0
0
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Strategy TO Prevent Decompensated Heart Failure
Role: collaborator
Seerlinq: Non-invasive LVFP Monitoring in HF
Role: collaborator
Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)
Role: lead
Score TO Predict SHOCK - STOP SHOCK
Role: lead
Atrial Fibrillation in Relationship to Plasma Biomarkers
Role: lead
Atrial Fibrillation in Relationship to Sleep Quality and Plasma Biomarkers
Role: lead
All 6 trials loaded